Serologic predictors of thyroid immune-related adverse events during immune checkpoint inhibitors therapy: a retrospective cohort study
Rationale: Immune-related adverse events (irAEs) are a specific type of drug toxicity that can occur in cancer patients undergoing immunotherapy with immune checkpoint inhibitors (ICIs). Endocrine irAEs rank the 3rd after the skin and gastrointestinal ones. Clinical course of endocrine irAEs usually...
Main Authors: | Anastasia A. Glibka, Natalia V. Mazurina, Ksenia A. Sarantseva, Galina Y. Kharkevich, Mikhail V. Volkonskii, Alina R. Elfimova, Ekaterina A. Troshina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2024-12-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://almclinmed.ru/jour/article/viewFile/17329/1704 |
Similar Items
-
Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy
by: A. A. Glibka, et al.
Published: (2024-04-01) -
Serum thyroid autoantibodies in malignant thyroid nodules
by: Towhidur Rahman Awal, et al.
Published: (2024-08-01) -
Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo
by: Yifen Yang, et al.
Published: (2014-01-01) -
Evaluation of thyroid dysfunction and thyroid autoantibodies in patients with Vitiligo
by: Mohammadi R, et al.
Published: (2016-06-01) -
Association of Anti-Thyroglobulin and Anti-Thyroid Peroxidase Antibodies in Patients with Primary Hypothyroidism
by: Taghreed S. Saeed Al-Rawi, et al.
Published: (2023-12-01)